Disparate Candida albicans Biofilm Formation in Clinical Lipid Emulsions Due to Capric Acid-Mediated Inhibition | Zendy

Hubertine M. E. Willems | Zendy; Jeremy S. Stultz | Zendy; Molly E. Coltrane | Zendy; Jabez P. Fortwendel | Zendy; Brian M. Peters | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Disparate Candida albicans Biofilm Formation in Clinical Lipid Emulsions Due to Capric Acid-Mediated Inhibition

Author(s) -

Hubertine M. E. Willems,

Jeremy S. Stultz,

Molly E. Coltrane,

Jabez P. Fortwendel,

Brian M. Peters

Publication year - 2019

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.01394-19

Subject(s) - biofilm , candida albicans , corpus albicans , capric acid , microbiology and biotechnology , chemistry , biology , biochemistry , bacteria , fatty acid , genetics , lauric acid

Receipt of parenteral nutrition (PN) remains an independent risk factor for developing catheter-related bloodstream infections (CR-BSI) caused by fungi, including by the polymorphic fungusCandida albicans , which is notoriously adept at forming drug-resistant biofilm structures. Among a variety of macronutrients, PN solutions contain lipid emulsions to supply daily essential fats and are often delivered via central venous catheters (CVCs).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research